日付

担当者

まとめ

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.

井部

Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial 

Lancet 2019

日付

担当者

まとめ

日付

担当者

まとめ

Time-Series Analysis of Health Care-Associated Infections in a New Hospital With All Private Rooms.

Follow-up Blood Cultures in Gram-Negative Bacteremia: Are They Needed?

Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.

日付

担当者

まとめ

日付

担当者

まとめ

Association of Household Income With Life Expectancy and Cause-Specific Mortality in Norway, 2005-2015

JAMA2019

Effect of a Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Hospitalized Patients With Chronic Obstructive Pulmonary Disease

JAMA2019

Influence of radiologic expertise in detecting lung tumors on chest radiographs.

Diagnostic and Intervention

 Imaging  2018